Why the study?
Survival and quality of life in patients treated by TAVI compared to an age- and sex-matched general population were not well known.
Does survival and quality of life in patients treated with TAVI compare favorably to the age- and sex-matched general population?
Population
5489 TAVI patients from the Netherlands Heart Registration (period 2013-2017)
Comparison
TAVI patients vs Dutch age- and sex-matched general population
Design
Registry-based cohort study
Follow-up
5 years
Authors
Loading...
Supports TAVI matching general-population survival in octogenarians; leaves open randomized confirmation versus medical therapy.
Does survival and quality of life in patients treated with TAVI compare favorably to the age- and sex-matched general population?
TAVI restores survival and quality of life to levels comparable to the general population in patients aged 80 years and older.
Zelis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: